I. Magdó

发表

Introduction to structure and ligand-based drug design

G. Náray-Szabó, G. Keserü, I. Magdó, 2002 .

Discovery of New Heterocyclic Ring Systems as Novel and Potent V1A Receptor Antagonists.

Z. Szakács, Z. Béni, F. Baska, 2020, ACS chemical neuroscience.

Infrared and Raman spectra of bicyclic molecules using scaled noncorrelated and correlated ab initio force fields

T. Klots, I. Magdó, W. Collier, 1999 .

The reliability of scaled quantum mechanical (SQM) force fields at the MINDO/3 level as studied on nitrogen- heteroaromatics

G. Fogarasi, G. Pongor, I. Magdó, 1994 .

Theoretical prediction of vibrational spectra. The a priori scaled quantum mechanical (SQM) force field and vibrational spectra of pyrimidine

G. Fogarasi, J. E. Boggs, G. Keresztury, 1992 .

Novel imidazo[1,5-a]quinoxaline derivatives: SAR, selectivity and modeling challenges en route to the identification of an α5-GABAA receptor NAM.

I. Magdó, Attila Potor, B. Krámos, 2022, Bioorganic & medicinal chemistry letters.

A priori results for molecular geometry, scaled quantum mechanical (SQM) force field, and vibrational spectra of pyridazine

G. Fogarasi, P. Szalay, A. Bérces, 1993 .

A Low-Temperature Phase of 2-Pyrrolidone

K. Schaffner, R. Goddard, I. Magdó, 1998 .

Calculation of the Vibrational Spectra of Linear Tetrapyrroles. 2. Resonance Raman Spectra of Hexamethylpyrromethene Monomers

K. Németh, C. Védova, I. Magdó, 2000 .

Calculation of Vibrational Spectra of Linear Tetrapyrroles. 1. Global Sets of Scaling Factors for Force Fields Derived by ab Initio and Density Functional Theory Methods

P. Hildebrandt, K. Schaffner, K. Németh, 1999 .

Selective NR1/2B N-methyl-D-aspartate receptor antagonists among indole-2-carboxamides and benzimidazole-2-carboxamides.

B. Ágai, A. Gere, G. Keserü, 2007, Journal of medicinal chemistry.

Novel sulfonamides having dual dopamine D2 and D3 receptor affinity show in vivo antipsychotic efficacy with beneficial cognitive and EPS profile.

J. Galambos, É. Schmidt, B. Kiss, 2007, Bioorganic & medicinal chemistry letters.

Development of Dual V1a/V2 Antagonists Containing Triazolobenzazepine Scaffold

F. Baska, I. Magdó, M. Vastag, 2024, European Journal of Medicinal Chemistry.